| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride |
| Available forms, composition and doses of Mint-Ondansetron: |
| Tablets; Oral; Ondansetron Hydrochloride 4 mgTablets; Oral; Ondansetron Hydrochloride 8 mg |
| Mint-Ondansetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Mint Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Helmine | Ondansetron Hydrochloride | GlaxoSmithKline |
| Izofran | Ondansetron Hydrochloride | GlaxoSmithKline |
| Izofran Zydis | Ondansetron Hydrochloride | GlaxoSmithKline |
| Jamp-Ondansetron | Ondansetron Hydrochloride | Jamp Pharma |
| Lametic | Ondansetron Hydrochloride | Landson |
| Modifical | Ondansetron Hydrochloride | Asofarma de Mexico; Zodiac Produtos Farmaceuticos |
| Nausedron | Ondansetron Hydrochloride | Cristalia Produtos Quimicos Farmaceuticos |
| Nosirid | Ondansetron Hydrochloride | Plus India |
| Novatron | Ondansetron Hydrochloride | Radicura Pharmaceuticals |
| Nozuca | Ondansetron Hydrochloride | Darvys Pharma; RBC-MDC Corporation |